title: Power morcellators: a review of current practice and assessment of risk.
abstract: Power morcellation has come under scrutiny because of a highly publicized case of disseminated leiomyosarcoma following a laparoscopic hysterectomy. A recent Federal and Drug Administration safety communication discouraging use of power morcellators on presumed uterine leiomyoma further highlights the need for reexamination of uterine tissue extraction. This clinical opinion aims to summarize current approaches to uterine/fibroid tissue extraction including the associated immediate and long-term potential risks of open power morcellation. The known data about risk of uterine sarcoma is reviewed followed by a discussion of acceptable risk and informed consent in the context of shared-decision making.
authors: Department of Obstetrics and Gynecology, NorthShore University HealthSystem, Evanston, IL. Electronic address: ssenapati@northshore.org.
authors: Sangeeta
authors: S
authors: Senapati
authors: Department of Obstetrics and Gynecology, NorthShore University HealthSystem, Evanston, IL.
authors: Frank F
authors: FF
authors: Tu
authors: Department of Obstetrics and Gynecology, Mayo Clinic, Scottsdale, AZ.
authors: Javier F
authors: JF
authors: Magrina
mesh_terms: D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods; D007889:Leiomyoma / Q000601:surgery*; D010818:Practice Patterns, Physicians'; D018570:Risk Assessment; D014594:Uterine Neoplasms / Q000601:surgery*
keywords: hysterectomy; leiomyoma; morcellation; myomectomy; uterine malignancy